Chief Operating Officer, API Innovation Center
Kevin is the Chief Operating Officer of the API Innovation Center (APIIC), a nonprofit public benefit organization headquartered in St. Louis, Missouri, dedicated to driving health security and economic growth for the nation and its citizens through U.S.-based production of critical medicines. Leading the API Center’s efforts at a national and regional level to strengthen domestic pharmaceutical manufacturing in the U.S., he is directly responsible for business operations, programs, strategy and external engagement. Kevin is a subject matter expert and featured speaker on the importance of securing our national health security.
His expertise is managing uncertainty and achieving results. A highly respected, connected and trusted representative of the pharmaceutical industry, Kevin led pharmaceutical Government Affairs and Advocacy teams including multi-stakeholder coalitions to successfully lobby for Medicare expansion of patient treatment. He is currently leading efforts to strengthen domestic pharmaceutical manufacturing in the United States at the APIIC. As a thirty-year veteran of the healthcare care community, Kevin has broad, cross-functional technical expertise in government affairs, communications, manufacturing, operations, sales and brand management.
As the pharmaceutical industry evolves, ensuring a resilient, efficient, and scalable biopharma manufacturing ecosystem is critical for national health security. This panel, led by APIIC, brings together experts from academia, industry, and advanced manufacturing to discuss how cutting-edge technologies, strategic public-private partnerships, and infrastructure optimization are shaping the future of drug production. With a mission to strengthen the U.S. pharmaceutical supply chain, APIIC plays a pivotal role in uniting government agencies, research institutions, and manufacturers to accelerate novel pharmaceutical manufacturing solutions. Panelists will explore the latest advancements in continuous manufacturing, automation, and AI-driven process optimization, along with strategies to maximize the potential of underutilized facilities to expand domestic production capacity.